... carrying the prostate-specific IGF-1R knockout alleles with transgenic mice that develop spontaneous prostate cancer when p53 and select other genes are compromised. The results were as predicted: ...
... as it sounds, scientists at the Garvan Institute for Medical Research have shown that there is a link between prostate cancer and a higher risk of bone fracture. Analysis of data from Garvan’s Dubbo ...
... markers and growth factors in human tissue known to be important for development and progression of prostate cancer,” he said. “It’s this work we hope will lead to longer term prevention strategies ...
... external-beam radiation therapy (EBRT) for localized prostate cancer may be at an increased risk for secondary malignancy, ... 3.0-fold increase for cystectomy for bladder cancer, 1.8-fold rate of lung- ...
Patients undergoing external-beam radiation therapy for localized prostate cancer may be at an increased risk for secondary malignancy, according to a new study.
... Orlando, African-American men with known prostate cancer risk factors with baseline levels ... African-American men with a family history of prostate cancer. The volunteers were divided into three groups ...
... ) is an effective method for locating the prostatic apex for radiation therapy treatment planning in prostate cancer patients because it eliminates the need for an invasive procedure and the related ...
... be done in about seven minutes, can overcome that challenge, he said.
HIFU is becoming more common as a prostate cancer treatment option, particularly for those persons who can’t or don’t want to ...
... that adenomas occurred in the treated animals. “Adenomas are not commonly found to be part of prostate-cancer development in this system,” he says. “This drug appears to shift tumor progression from ...
An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows. The agent, OSU-HDAC42, belongs to a new class of ...
... molecular pathways appear to play a crucial role in regulating (and encouraging) this aggressive subset of prostate cancer.
While estrogen is typically thought of as a "female" hormone, men ...
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone - the hormone that ...
... in Chicago.
"From what we have seen, this shows that the immune system can be useful to treat prostate cancer. Results show that in some patients, the immune system can be successfully harnessed to ...
... leukemias and lymphomas, but not in common solid tumors such as prostate cancer. Chinnaiyan's discovery demonstrated that these gene ... prostate cancer www2.med.umich.edu/prmc/media/newsroom/details.cfm ...
... in urine and SPINK1 outlier expression was shown to be an effective independent predictor of prostate cancer recurrence after surgical resection. Further, the aggressive ETS-negative 22RV1 cell line ...
